Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1995-12-15
|
pubmed:abstractText |
Over a 9-month period from September of 1991 to May of 1992, 339 patients were included in a randomized, double-blind, placebo-controlled study using azithromycin as the prophylactic agent to determine whether it effects a clinically meaningful reduction in postoperative surgical infections in plastic surgery. Azithromycin was given as prophylaxis in 171 patients and placebo in 168 patients. The study medication was a single oral dose taken at 8 P.M. the day before surgery. The patients were followed up for a minimum of 4 weeks after surgery. The patients who received wound infection prophylaxis had 5.1 percent infections compared with 20.5 percent in the placebo group (p = 0.00009). Eighty percent of all wound infections were first seen after discharge, explaining why plastic surgeons might overlook their infectious complications. There was a significant reduction in postoperative complications (p = 0.04) and in the additional use of antibiotics postoperatively (p = 0.007) in the prophylaxis group. Subgroup analysis showed a significant reduction in surgical infections in breast surgery (p < 0.05) and reconstructive surgery with flaps (p < 0.05). No effect of the prophylactic regime was demonstrated in patients undergoing secondary surgery for cleft lip and palate disease.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0032-1052
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
96
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1378-83
|
pubmed:dateRevised |
2011-2-16
|
pubmed:meshHeading |
pubmed-meshheading:7480237-Adult,
pubmed-meshheading:7480237-Anti-Bacterial Agents,
pubmed-meshheading:7480237-Antibiotic Prophylaxis,
pubmed-meshheading:7480237-Azithromycin,
pubmed-meshheading:7480237-Child,
pubmed-meshheading:7480237-Double-Blind Method,
pubmed-meshheading:7480237-Female,
pubmed-meshheading:7480237-Humans,
pubmed-meshheading:7480237-Male,
pubmed-meshheading:7480237-Prospective Studies,
pubmed-meshheading:7480237-Surgery, Plastic,
pubmed-meshheading:7480237-Surgical Wound Infection
|
pubmed:year |
1995
|
pubmed:articleTitle |
A prospective, double-blind, placebo-controlled trial of a single dose of azithromycin on postoperative wound infections in plastic surgery.
|
pubmed:affiliation |
Department of Plastic Surgery, Norwegian National Hospital, Oslo, Norway.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|